59987-31-4

Basic information

• Product Name: 5-Amino-2,4-dichloropyrimidine
• Synonyms: 5-Pyrimidinamine, 2,4-dichloro-
• CAS NO: 59987-31-4
• Molecular Formula: C₄H₃Cl₂N₃
• Molecular Weight: 211.174
• Mol File: 59987-31-4.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 290.7 °C at 760 mmHg
• Flash Point: 129.6 °C
• Density: 1.606 g/cm³
• CAS DataBase Reference: 5-Amino-2,4-dichloropyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Amino-2,4-dichloropyrimidine(59987-31-4)
• EPA Substance Registry System: 5-Amino-2,4-dichloropyrimidine(59987-31-4)

Safety Data

• Hazardous Substances Data: 59987-31-4(Hazardous Substances Data)

Upstream product

• 3316-09-4 1,2-dihydroxy-4-nitrobenzene 
• 3132-64-7 1,2-Epoxy-3-bromopropane 
• 107-83-5 2-Methylpentane 
• 3663-82-9 2-hydroxymethyl-2,3-dihydrobenzo[1,4]dioxin 
• 682339-44-2 3-nitro-6-allyloxyphenol epoxide 
• 106-89-8 epichlorohydrin 

Downstream Products

• 1064662-68-5 [7-nitro-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate 
• 1415679-99-0 4-((7-nitro-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methoxy)benzonitrile 
• 1415680-05-5 ethyl 2-(benzyl(2-((4-cyanophenoxy)methyl)-2,3-dihydrobenzo[b][1,4]dioxin-7-yl)amino)-2-oxoacetate 
• 1415680-01-1 C₁₆H₁₄N₂O₃ 
• 1415680-03-3 4-((7-(benzylamino)-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methoxy)benzonitrile 

Relevant articles and documents

3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division

Lipophilic substituents at benzodioxane C (7) of 3-(benzodioxan-2-ylmethoxy)-2,6-difluorobenzamide improve the antibacterial activity against methicillin-resistant Staphylococcus aureus strains to MIC values in the range of 0.2-2.5 μg/mL, whereas hydrophi

OXINDOLEDIOXANS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO

The present invention provides methods for preparing compounds having activity as dopamine autoreceptor agonists and partial agonists at the postsynaptic dopamine D2 receptor. These compounds are useful for treating dopaminergic disorders, such

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.